Apellis Pharmaceuticals APLS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 22.63 | 98.06 | 1.72 | 223,183 | 216 | |
| 2025Q2 | 17.31 | 109.02 | -0.33 | -33,286 | -42 | |
| 2025Q1 | 21.87 | 103.08 | -0.74 | -83,328 | -92 | |
| 2024Q4 | 31.91 | 106.65 | -0.29 | -26,164 | -36 | |
| 2024Q3 | 28.84 | 106.68 | -0.47 | -47,281 | -57 | |
| 2024Q2 | 38.36 | 104.47 | -0.30 | -29,444 | -38 | |
| 2024Q1 | 58.78 | 104.73 | -0.54 | -62,090 | -66 | |
| 2023Q4 | 59.86 | 105.98 | -0.72 | -84,518 | -89 | |
| 2023Q3 | 38.04 | 103.30 | -1.16 | -137,079 | -140 | |
| 2023Q2 | 91.10 | 105.19 | -1.01 | -120,441 | -122 | |
| 2023Q1 | 65.96 | 103.01 | -1.56 | -175,083 | -178 | |
| 2022Q4 | 51.71 | 102.71 | -1.50 | -164,053 | -166 | |
| 2022Q3 | 68.30 | 83.61 | -1.77 | -152,938 | -191 | |
| 2022Q2 | 45.22 | 101.08 | -1.46 | -148,624 | -156 | |
| 2022Q1 | 50.81 | 99.85 | -1.42 | -128,998 | -139 | |
| 2021Q4 | 47.28 | 61.84 | -1.53 | -89,404 | -148 | |
| 2021Q3 | 32.96 | 66.22 | -2.27 | -127,995 | -196 | |
| 2021Q2 | 63.20 | 90.19 | -2.72 | -194,287 | -219 | |
| 2021Q1 | 42.91 | 69.42 | -2.32 | -124,591 | -184 | |
| 2020Q4 | 57.20 | 145.03 | 1.06 | 130,121 | 78 |